283 related articles for article (PubMed ID: 24107627)
1. Reprogramming of non-genomic estrogen signaling by the stemness factor SOX2 enhances the tumor-initiating capacity of breast cancer cells.
Vazquez-Martin A; Cufí S; López-Bonet E; Corominas-Faja B; Cuyàs E; Vellon L; Iglesias JM; Leis O; Martín AG; Menendez JA
Cell Cycle; 2013 Nov; 12(22):3471-7. PubMed ID: 24107627
[TBL] [Abstract][Full Text] [Related]
2. Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway.
Corominas-Faja B; Cufí S; Oliveras-Ferraros C; Cuyàs E; López-Bonet E; Lupu R; Alarcón T; Vellon L; Iglesias JM; Leis O; Martín ÁG; Vazquez-Martin A; Menendez JA
Cell Cycle; 2013 Sep; 12(18):3109-24. PubMed ID: 23974095
[TBL] [Abstract][Full Text] [Related]
3. The mitotic kinase Aurora--a promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERα(+) breast cancer cells.
D'Assoro AB; Liu T; Quatraro C; Amato A; Opyrchal M; Leontovich A; Ikeda Y; Ohmine S; Lingle W; Suman V; Ecsedy J; Iankov I; Di Leonardo A; Ayers-Inglers J; Degnim A; Billadeau D; McCubrey J; Ingle J; Salisbury JL; Galanis E
Oncogene; 2014 Jan; 33(5):599-610. PubMed ID: 23334326
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor α signaling regulates breast tumor-initiating cells by down-regulating miR-140 which targets the transcription factor SOX2.
Zhang Y; Eades G; Yao Y; Li Q; Zhou Q
J Biol Chem; 2012 Nov; 287(49):41514-22. PubMed ID: 23060440
[TBL] [Abstract][Full Text] [Related]
5. VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2.
Zhao D; Pan C; Sun J; Gilbert C; Drews-Elger K; Azzam DJ; Picon-Ruiz M; Kim M; Ullmer W; El-Ashry D; Creighton CJ; Slingerland JM
Oncogene; 2015 Jun; 34(24):3107-19. PubMed ID: 25151964
[TBL] [Abstract][Full Text] [Related]
6. Long Non-Coding RNA HOTAIR Regulates the Proliferation, Self-Renewal Capacity, Tumor Formation and Migration of the Cancer Stem-Like Cell (CSC) Subpopulation Enriched from Breast Cancer Cells.
Deng J; Yang M; Jiang R; An N; Wang X; Liu B
PLoS One; 2017; 12(1):e0170860. PubMed ID: 28122024
[TBL] [Abstract][Full Text] [Related]
7. Estrogen promotes stemness and invasiveness of ER-positive breast cancer cells through Gli1 activation.
Sun Y; Wang Y; Fan C; Gao P; Wang X; Wei G; Wei J
Mol Cancer; 2014 Jun; 13():137. PubMed ID: 24889938
[TBL] [Abstract][Full Text] [Related]
8. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
[TBL] [Abstract][Full Text] [Related]
9. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
[TBL] [Abstract][Full Text] [Related]
10. DDX17 (P72), a Sox2 binding partner, promotes stem-like features conferred by Sox2 in a small cell population in estrogen receptor-positive breast cancer.
Alqahtani H; Gopal K; Gupta N; Jung K; Alshareef A; Ye X; Wu F; Li L; Lai R
Cell Signal; 2016 Feb; 28(2):42-50. PubMed ID: 26569340
[TBL] [Abstract][Full Text] [Related]
11. The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells.
Ariazi EA; Brailoiu E; Yerrum S; Shupp HA; Slifker MJ; Cunliffe HE; Black MA; Donato AL; Arterburn JB; Oprea TI; Prossnitz ER; Dun NJ; Jordan VC
Cancer Res; 2010 Feb; 70(3):1184-94. PubMed ID: 20086172
[TBL] [Abstract][Full Text] [Related]
12. Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors.
Nishi M; Sakai Y; Akutsu H; Nagashima Y; Quinn G; Masui S; Kimura H; Perrem K; Umezawa A; Yamamoto N; Lee SW; Ryo A
Oncogene; 2014 Jan; 33(5):643-52. PubMed ID: 23318426
[TBL] [Abstract][Full Text] [Related]
13. Sox2 expression in breast tumours and activation in breast cancer stem cells.
Leis O; Eguiara A; Lopez-Arribillaga E; Alberdi MJ; Hernandez-Garcia S; Elorriaga K; Pandiella A; Rezola R; Martin AG
Oncogene; 2012 Mar; 31(11):1354-65. PubMed ID: 21822303
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
Bourguignon LY; Wong G; Earle C; Chen L
J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
[TBL] [Abstract][Full Text] [Related]
15. Basal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin).
Martin-Castillo B; Oliveras-Ferraros C; Vazquez-Martin A; Cufí S; Moreno JM; Corominas-Faja B; Urruticoechea A; Martín ÁG; López-Bonet E; Menendez JA
Cell Cycle; 2013 Jan; 12(2):225-45. PubMed ID: 23255137
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility of pancreatic cancer stem cells to reprogramming.
Noguchi K; Eguchi H; Konno M; Kawamoto K; Nishida N; Koseki J; Wada H; Marubashi S; Nagano H; Doki Y; Mori M; Ishii H
Cancer Sci; 2015 Sep; 106(9):1182-7. PubMed ID: 26298849
[TBL] [Abstract][Full Text] [Related]
17. Interrogating Estrogen Signaling Pathways in Human ER-Positive Breast Cancer Cells Forming Bone Metastases in Mice.
Cheng JN; Frye JB; Whitman SA; Ehsani S; Ali S; Funk JL
Endocrinology; 2024 Apr; 165(6):. PubMed ID: 38715255
[TBL] [Abstract][Full Text] [Related]
18. Differential ERα-mediated rapid estrogenic actions of ginsenoside Rg1 and estren in human breast cancer MCF-7 cells.
Gao QG; Chan HY; Man CW; Wong MS
J Steroid Biochem Mol Biol; 2014 May; 141():104-12. PubMed ID: 24508513
[TBL] [Abstract][Full Text] [Related]
19. Sodium arsenite inhibited genomic estrogen signaling but induced pERα (Ser118) via MAPK pathway in breast cancer cells.
Nakareangrit W; Thiantanawat A; Visitnonthachai D; Watcharasit P; Satayavivad J
Environ Toxicol; 2016 Sep; 31(9):1133-46. PubMed ID: 25728338
[TBL] [Abstract][Full Text] [Related]
20. Obesity enhances nongenomic estrogen receptor crosstalk with the PI3K/Akt and MAPK pathways to promote in vitro measures of breast cancer progression.
Bowers LW; Cavazos DA; Maximo IX; Brenner AJ; Hursting SD; deGraffenried LA
Breast Cancer Res; 2013; 15(4):R59. PubMed ID: 23880059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
